Well put mate. Not a sheep station for me but have some to...

First 9 Last

Share
Profile

Follow
sle

10,822 Posts.

349

26/10/22

10:05

Post #: 64399916
Share

Originally posted by davybabyk: ↑

Well - that's reassuring news, although reasonably expected.

I'm still on the sidelines with this one. The need for a neuroprotective drug is simply massive. The market for their initial key focus of stroke treatment would be incredible - if it works. And then there is the range of other potential applications - infant/birth related hypoxia; concussion and other mild TBI; hypoxia from cardiac events, etc.

So the preclinical data indicating effectiveness looks good, and so far they have minimal toxicity in humans - also good.

What gives me pause is the fact that so many other attempts at producing a neuroprotective drug have failed to show a beneficial effect in humans.
Around 1,000 drug investigated so far, with 100 going to clinical studies, and nothing yet proven (NA1 is still a possible, but has it's own problems). This seems to be an area of medical research in which animal studies do not give an accurate indication of effect in human subjects. Lots of things seem to work in rats, mice etc, but when tried in human objects the results are minimal or negative.

Eventually, someone is likely to succeed. Maybe Prof Meloni is that someone, and AGN will be the team which brings it to fruition. If so - it will be worth billions. Current market cap is just $43.6 million.

Statistically, the odds are against them - but maybe they will succeed. I hope they do!!! It' an interesting risk vs reward situation.

I'm still inclined to take a position, but I'm also still reading....

Existing holders - Please do not take this as a criticism of AGN, or of your decision to invest. Investing in AGN is a perfectly rational thing to do, and it may prove to be life changing - for investors as well as patients. I'm just trying to assess how much I am prepared to risk here.

Cheers

Dave

Expand

Well put mate. Not a sheep station for me but have some to hopefully see it through to commercial production.

AGN Price at posting: 50.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Finance school vs reality: What they don't teach you about the stock market

Making money: How many microcaps should be in an investor's portfolio?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

There are more pages in this discussion • 6 more messages in this thread...

First 9 Last

Add AGN (ASX) to my watchlist

(20min delay)
Last 71.0¢		Change -0.040(5.33%)		Mkt cap ! $90.94M

Open	High	Low	Value	Volume
73.0¢	73.0¢	70.5¢	$123.8K	170.7K

Buyers (Bids)

No.	Vol.	Price($)
2	22605	70.0¢

Sellers (Offers)

Price($)	Vol.	No.
75.0¢	5791	2

View Market Depth

No.	Vol.	Price($)
2	22605	0.700
1	15000	0.695
2	39400	0.690
1	12000	0.680
2	51052	0.665

Price($)	Vol.	No.
0.750	5791	2
0.760	5660	1
0.765	12778	1
0.790	26800	1
0.795	39999	1

Last trade - 15.58pm 28/10/2024 (20 minute delay)

AGN (ASX) Chart

Well put mate. Not a sheep station for me but have some to...

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Finance school vs reality: What they don't teach you about the stock market

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Well put mate. Not a sheep station for me but have some to...

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

Finance school vs reality: What they don't teach you about the stock market

Making money: How many microcaps should be in an investor's portfolio?

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News